N. А. Totolyan

NА

Statistics

Publications

Citations

1.2K

H-Index

Active since

2017

Affiliations

First Pavlov State Medical University of St. Petersburg(Current)

Johns Hopkins University

National Cancer Center

Tohoku Medical and Pharmaceutical University

Cheng Hsin General Hospital

N. А. Totolyan is an author at First Pavlov State Medical University of St. Petersburg specializing in multiple sclerosis, life sciences, and neurology.

ORCID

Publications per year

2017–2023

Publications

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

Sean J. Pittock, Achim Berthele, Kazuo Fujihara et al. · New England Journal of Medicine · 2019 · 846 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial

Daniel S. Reich, Douglas L. Arnold, Patrick Vermersch et al. · The Lancet Neurology · 2021 · 192 citations · Full text

Medicine, Neurology, Pharmacology +9

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

Amit Bar‐Or, Heinz Wiendl, Xavier Montalbán et al. · Multiple Sclerosis Journal · 2021 · 62 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Leptomeningeal Contrast Enhancement Is Associated with Disability Progression and Grey Matter Atrophy in Multiple Sclerosis

Gleb Makshakov, N. А. Totolyan, E. Verbitskaya et al. · Neurology Research International · 2017 · 50 citations · Full text

Medicine, Neurology, Neuroscience +17

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

Jacqueline Palace, Dean M. Wingerchuk, Kazuo Fujihara et al. · Multiple Sclerosis and Related Disorders · 2020 · 40 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

1–5 of 8